Hepcidin plays a crucial role in the pathogenesis of renal anaemia in CKD, and its elevated levels not only contribute to functional iron deficiency and resistance to erythropoiesis-stimulating agents but also may serve as a valuable biomarker for both renal anaemia management and cardiovascular disease prognosis [65]. This evidence concerns the gene HAMP and chronic kidney disease.